Results 111 to 120 of about 23,422 (206)

Organ Transplantation: Current Status, Challenges, and Future Prospects

MedComm, Volume 7, Issue 1, January 2026.
Organ transplantation success relies on precise modulation of the alloimmune response across distinct temporal phases of rejection. Hyperacute rejection results from preformed antibodies activating complement and causing thrombosis, while acute rejection involves T cell‐ and antibody‐mediated mechanisms that drive endothelial activation and ...
Xinqiang Li, Ruidong Ding, Jinzhen Cai
wiley   +1 more source

Dextran vs. Crystalloid Priming Solution in Cardiac Surgery: A Randomized Trial on Acute Kidney Injury

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 1, January 2026.
ABSTRACT Background Acute kidney injury (AKI) is a frequent complication following cardiac surgery involving cardiopulmonary bypass (CPB). This is partly attributable to crystalloid‐based priming solutions causing both hemolysis and loss of oncotic pressure with tissue edema. While colloids like albumin and starches have not shown clear benefits, pilot
Oskar Juvakka, Andreas Wallinder, Peter Hasse Møller‐Sørensen, Klaus Matschke, Anders Jeppsson, Lukas Lannemyr   +5 more
wiley   +1 more source

Transoperative refusion: a simple and safe method in emergency surgery

Revista do Colégio Brasileiro de Cirurgiões
The objective is to reinforce the importance of blood reinfusion as a cheap, safe and simple method, which can be used in small hospitals, especially those in which there is no blood bank.
Luiz Carlos Buarque Gusmão, Sérgio Henrique Chagas Valoes, José da Silva Leitão Neto   +2 more
doaj   +1 more source

Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysis. [PDF]

Bone Marrow Transplant, 2021
Farhadfar N, Murthy HS, Logan BR, Sees JA, Ayas M, Battiwalla M, Beitinjaneh AM, Chhabra S, Diaz MA, Engles K, Frangoul H, Ganguly S, Gergis U, Kamani NR, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Norkin M, O' Donnell PV, Olsson RF, Rossmann S, Savani BN, Schears R, Seo S, Solh MM, Spitzer T, Sugrue M, Yared JA, Linenberger M, Schwartz J, Pulsipher MA, Shah NN, Switzer GE, Confer DL, Shaw BE, Wingard JR.   +36 more
europepmc   +1 more source

Retraction Notice to: lncRNA MALAT1 Accelerates Wound Healing of Diabetic Mice Transfused with Modified Autologous Blood via the HIF-1α Signaling Pathway [PDF]

, 2022
Xiaoqian Liu, Li‐Shuang Duan, Yong Q. Chen, Jin Xiao-ju, Na‐Na Zhu, Xun Zhou, Han‐Wei Wei, Lei Yin, Jian‐Rong Guo   +8 more
openalex   +1 more source

Role of Frailty in Assessing Eligibility for CAR T‐Cell Therapy in Haematology

European Journal of Haematology, Volume 116, Issue 1, Page 4-13, January 2026.
ABSTRACT Background and Objectives Frailty is a key consideration in determining whether a patient is robust enough for CAR T‐cell therapy; however, it should not represent a barrier to treatment. Our study aimed to describe the extent of research concerning frailty in haematology adult and paediatric patients being considered for CAR T‐cell therapy ...
Jennifer Clesham, Joan McGrory, Aoife Bannon, Deirbhle Cox, Maura Dowling   +4 more
wiley   +1 more source

Autologous Blood Transfusion in Elective Orthopaedic Surgery [PDF]

, 1987
Shamagonam James, Michael A. Smith
openalex   +1 more source

Impact of Anemia on Outcomes Following Total Hip Replacement Surgery and Patient Prognosis

Orthopaedic Surgery, Volume 18, Issue 1, Page 3-15, January 2026.
The processes involved in iron acquisition are closely controlled by hepcidin‐based regulatory mechanisms. Hepcidin is a peptide hormone mainly produced in the liver, acting as an acute‐phase reactant that responds to changes in plasma iron levels. It does this by binding to ferroportin, a protein responsible for exporting iron from cells, leading to ...
Zhihong Hu, Xuejia Zhao, Zhang Chen
wiley   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source

[Clinical effects of medical ozone autologous blood transfusion combined with Xingnaojing in the treatment of septic encephalopathy in burns]. [PDF]

Zhonghua Shao Shang Za Zhi, 2021
Ye XY, Li XL, Li YG, Li YC, Xiao HT, Zhang J, Zhao XK, Xia CD, Tian SM, Feng K.   +9 more
europepmc   +1 more source